Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.
D000406:AKR murine leukemia virus / Q000276:immunology*; D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000276:immunology*; D003433:Crosses, Genetic; D005260:Female; D007116:Immunization, Passive; D009052:Leukemia Virus, Murine / Q000276:immunology*; D007942:Leukemia, Experimental / Q000276:immunology*; D051379:Mice; D008806:Mice, Inbred AKR / Q000276:immunology; D011247:Pregnancy; D013997:Time Factors; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000276:immunology*; D014766:Viremia
D000914:Antibodies, Viral; D014759:Viral Envelope Proteins; D014764:Viral Proteins